Hypertension treatment and control in sub-Saharan Africa: The epidemiological basis for policy

British Medical Journal

Volumn 316, Issue 7131, 1998, Pages 614-617

  Cooper, Richard S ^a   Rotimi, Charles N ^b   Kauftnan, Jay S ^c   Muna, Walinjom F T ^a   Mensah, George A ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b University of Health Sciences   (Cameroon)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

AFRICA; BLOOD PRESSURE REGULATION; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DRUG COST; HEALTH CARE POLICY; HUMAN; HYPERTENSION; MORTALITY; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SHORT SURVEY; SOCIAL PSYCHOLOGY; SYSTOLIC BLOOD PRESSURE;

EID: 0032554272     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7131.614     Document Type: Short Survey

References (37)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-76.
2. Feachem RG, Jamison DT, Bos ER. Changing patterns of disease and mortality in sub-Saharan Africa. In: Feachem RG, Jamison DT, eds. Disease and mortality in sub-Saharan Africa. Washington, DC: World Bank, 1991:3-27.
3. Feachem RGA, Kjellstron T, Murray CJL, Over M, Phillips MA, eds. The health of adults in the developing uvrleL Washington DC: World Bank, 1992:273.
4. Kaufman JS, Asuzu MC, Rotimi CN, Johnson OO, Owoaje EE, Cooper RS. The absence of adult mortality data for sub-Saharan Africa: a practical solution. Butf HWO 1997:75:389-95.
5. Asuzu MC, Johnson OO, Owoaje EE, Rotimi CNT, Kaufman JS, Cooper RS. Questions on adult mortality, World Health Forum 199G;17;373-6.
6. World Bank. Social indicators of development, 1990. Baltimore, MD: Johns Hopkins University Press, 1991.
7. Donnison CP. Blood pressure in the African native. Lancet 1929;i:6-l 1.
8. KaufmanJS, Barkey N. Hypertension in Africa: an overview of prevalence rates and causal risk factors. Ethnic Dis 1993;3(suppl):S83-101.
9. Poulter N, Khaw KT, Hopwood BEC, Mugambi M, Peart WS, Rose G, et al. Blood pressure and associated factors in a rural Kenyan community. Hypertension 1984;6:801-13.
10. Bunker CH, Ukoli FA, Nwankwo MU, OmcneJA, Currier GW, HoliSeld-Kennedy L. Factors associated with hypertension in Kigerian civil servants./Yro AW 1992:21:710-22.
11. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al. The prevalence of hypertension in seven populations of West African origin. Am] Public Health 1997;87:160-8.
12. Akinkugbe OO, ed. Non-communicable diseases in Nigeria: final report of a national survey. Lagos: Federal Ministry of Health and Social Services, 1997.
13. Cooper RS, Puras A, TracyJA, KaufmanJS, Ordunez PO, MufundaJ, et al. Evaluation of an electronic blood pressure device for epidemiologic studies. Blood Pressure Monitoring 1997;2:35-40.
14. Kaufman JS, Owaje EE, James SA, Rotimi C, Cooper RS. The determinants of hypertension in West Africa: Contribution of anthropometrie and dietary factors to urban-rural and socio-economic gradients. AmJ Epidemiol 1996;143:1203-18.
15. Kaufman JS, Durazo-Avizu RA, Rotimi CN, McOee DL, Cooper RS, for the International Collaborative Study on Hjpertension in Blacks. Obesity and hypertension prevalence in populations of African origin: results from the international collaborative study on hjpertension in blacks. Epidemiology 1996:7:398-405.
16. IG Bennett S, Wilkins IIA- Witliin-person variation in urinary sodium, potassium and creatinine concentrations, and their relationship to changes in die blood pressure of adult male Gambians. J Trop Med Hygiene 1993;96:267-73.
17. M'Buyamba-Kabangu JR, Fagard R, Lijnen P, Mbuy wa Mbuy R, Staessen J, Amery A. Blood pressure and urinary cations in the urban Bantu of Zaire. Am J Epidemiol 1986;124:957-6S.
18. Collins R, Pcto R, MacMahon S, Hebert P, Fiebach M l, Ederlein KA, et aL Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context Lancet 1990:335:827-38.
19. Kaufman JS, Rotimi CN, Brieger WR, Oladukun MA, Kadiri S, Osotimehin BO, et al. The mortality risk associated with hjpertension: preliminary results of a prospective study in rural Nigeria. J Hum Ilyperfcro 1996:10:461-4.
20. Stornier R. The primary prevention of hjpertension and the population blood pressure problem. In: M Marmot, P FJIiott, eds. Coronary heart disease epidemiology: from etiololgy to public health. New York: Oxford University Press, 1992:415-34.
21. Cooper RS, Osotimehin B, Kaufman J, Forrester T Adult mortality in Africa: what should we conclude in the absence of data? Lancet 1998:351:208-10.
22. Adetunji JA, Murray CJL, Evans TG. Causes of death in Africa: a review. Population Association of America annual meeting, New1 Orleans, LA, 9-11 May 1996. (Abstract.).
23. Project team, policy implications of adult morbidity and mortality: a preliminary report of die adult morbidity and mortality project, Tanzania, December, 1993. In: Veachem RG.Jamison DT, eds. Disease and mortality in sub-Saharan Africa. Washington, DC: The World Bank, 1991.
24. Murray CJL, Lopez AD. Evidence-based health policy-lessons from the global burden of disease study Science 1996;274:740-3.
25. Pearce KA, Furber CD, Psaty BM, KirkJ. Comparative cost-effectiveness of first-line drugs for uncomplicated hjpertension. AmJ Hypertens 1998 (in press).
26. Jamison DT, Mosley WH, eds. Disease control priorities in developing countries. New York: Oxford University Press, 1993.
27. Whelton PK, Brancaii FL, Appel LJ, Klag MJ.The challenge of hjpertension and atherosclerotic cardiovascular disease in economically developing countries. High Blood Pressure 1995;4:3G-45.
28. World Hjpertension League. Economics of hjpertension control. Bull WHO 1995:73:417-24.
29. Sjikowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hjpertension, long-term treatment and cardiovascular mortality. The Framingham heart study 1950 to 1990. Circulation 1996:93:697-703.
30. SHEP Cooperative Research Group. Prevention of stroke by antihjpertensive drug treatment in older persons with isolated systolic hjpertension: final results in the sj'stolic hjpertension in the elderly program (SHEP). JAMA 4 1991:265:3255-64.
31. Hjpertension Detection and Follow-up Program Group. Five-jear findings of the hjpertension detection and follow-up program. L Reduction in mortality of persons with high blood pressure, including mild hjpertension. JAMA 1979:242:2562-71.
32. Freis ED. The Veterans Administration cooperative studj-. In: Paul O, ed. Epidemiology and control of hypertension. New York: Sjrnposia Specialists, 1975:449-84.
33. Veterans Administration Cooperative Study Group on Antihjpertensive Agents. Effects of treatment onmorbidityin hjpertension: results in patienta with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA 1970:202:1028-34.
34. Veterans Administration Cooperative Study Group on Antihjpertensive Agents. Effects of treatment on morbidity in hjpertension: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52.
35. MRC Working Party. Medical Research Council trial of treatment of hjpertension in older adults: principal results. BMJ 1982:304:405-12.
36. Chalmers J. Treatment guidelines in hjpertension: current limitations and future solutions./Hypertens 1996;14(suppl 4):S3-8.
37. Joint National Committee on Detection, Evalution and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JN'C V). Arch Intern .Med 1993:153:154-83.